Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Chemoprevention of prostate cancer: the Prostate Cancer Prevention Trial.

Thompson IM, Coltman CA Jr, Crowley J.

Prostate. 1997 Nov 1;33(3):217-21.

PMID:
9365551
2.

Update on chemoprevention of prostate cancer.

Klein EA, Thompson IM.

Curr Opin Urol. 2004 May;14(3):143-9. Review.

PMID:
15069304
3.

Prostate cancer prevention trials in the USA.

Brawley OW, Parnes H.

Eur J Cancer. 2000 Jun;36(10):1312-5. Review.

PMID:
10882873
4.

The future of prostate cancer prevention.

Brawley OW, Barnes S, Parnes H.

Ann N Y Acad Sci. 2001 Dec;952:145-52. Review.

PMID:
11795434
5.

SELECT: the selenium and vitamin E cancer prevention trial.

Klein EA, Thompson IM, Lippman SM, Goodman PJ, Albanes D, Taylor PR, Coltman C.

Urol Oncol. 2003 Jan-Feb;21(1):59-65. Review.

PMID:
12684129
6.

Update on prostate cancer chemoprevention.

Lowe JF, Frazee LA.

Pharmacotherapy. 2006 Mar;26(3):353-9. Review.

PMID:
16503715
7.

[Prostate cancer chemoprevention].

Krysiak R, Okopień B, Szkróbka W, Herman ZS.

Przegl Lek. 2005;62(9):929-33. Review. Polish.

PMID:
16541732
8.

Can prostate cancer be prevented?

Klein EA.

Nat Clin Pract Urol. 2005 Jan;2(1):24-31. Review.

PMID:
16474573
9.

What's new in the field of prostate cancer chemoprevention?

Mahal K, Hernandez J, Basler JW, Thompson IM.

Curr Urol Rep. 2005 May;6(3):177-82. Review.

PMID:
15869721
10.

Prostate cancer: a serious disease suitable for prevention.

Fitzpatrick JM, Schulman C, Zlotta AR, Schröder FH.

BJU Int. 2009 Apr;103(7):864-70. doi: 10.1111/j.1464-410X.2008.08206.x. Review.

11.

Chemotherapeutic prevention studies of prostate cancer.

Djavan B, Zlotta A, Schulman C, Teillac P, Iversen P, Boccon Gibod L, Bartsch G, Marberger M.

J Urol. 2004 Feb;171(2 Pt 2):S10-3; discussion S13-4. Review.

PMID:
14713746
12.

The selenium and vitamin E cancer prevention trial.

Klein EA, Lippman SM, Thompson IM, Goodman PJ, Albanes D, Taylor PR, Coltman C.

World J Urol. 2003 May;21(1):21-7. Epub 2003 Mar 8. Review.

PMID:
12756490
13.

Should finasteride be used to prevent prostate cancer?

Fleshner N, Kulkarni G.

Curr Treat Options Oncol. 2006 Sep;7(5):346-54. Review.

PMID:
16904051
14.

The effects of 5alpha-reductase inhibitors on the natural history, detection and grading of prostate cancer: current state of knowledge.

Andriole G, Bostwick D, Civantos F, Epstein J, Lucia MS, McConnell J, Roehrborn CG.

J Urol. 2005 Dec;174(6):2098-104. Review.

PMID:
16280736
15.

Chemoprevention of prostate cancer with finasteride.

Canby-Hagino ED, Brand TC, Hernandez J, Thompson IM.

Expert Opin Pharmacother. 2006 May;7(7):899-905. Review.

PMID:
16634712
16.

Pharmacological approaches to reducing the risk of prostate cancer.

Rittmaster RS, Fleshner NE, Thompson IM.

Eur Urol. 2009 May;55(5):1064-73. doi: 10.1016/j.eururo.2009.01.037. Epub 2009 Feb 5. Review.

PMID:
19200641
17.

Selenium and vitamin E cancer prevention trial.

Klein EA.

Ann N Y Acad Sci. 2004 Dec;1031:234-41. Review.

PMID:
15753149
18.

Update on chemoprevention for prostate cancer.

Strope SA, Andriole GL.

Curr Opin Urol. 2010 May;20(3):194-7. doi: 10.1097/MOU.0b013e3283381966. Review.

PMID:
20216317
19.
20.

Prostate cancer: chemoprevention update 2005.

Fleshner N, Al Azab R.

Can J Urol. 2005 Jun;12 Suppl 2:2-4. Review.

PMID:
16018824

Supplemental Content

Support Center